The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for patients seeking to treat obesity. The new rule, which was proposed by the administration on Tuesday, would dramatically expand access to anti-obesity medications like Wegovy, Ozempic and Mounjaro. Until now, Medicare and Medicaid have only provided insurance coverage for these drugs when they are used to treat conditions such as diabetes.
